Related Experiment Video
Updated: Dec 10, 2025

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
The Enigma of Endothelium in COVID-19
Savneet Kaur1, Dinesh M Tripathi1, Angeera Yadav2
1Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.
Insights
The endothelium, especially in the lungs, plays a critical role in COVID-19 pathogenesis. Understanding this endothelium-based mechanism may lead to new biomarkers and treatments for severe COVID-19.
Area of Science:
- Immunology
- Pathology
- Vascular Biology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents with diverse clinical manifestations, from mild symptoms to severe respiratory failure.
- A dysregulated host immune response is implicated in COVID-19 mortality.
- Current research aims to elucidate COVID-19's underlying mechanisms for novel therapeutic strategies.
Purpose of the Study:
- To propose a significant role for the endothelium, particularly the pulmonary endothelium, in the pathogenesis of COVID-19.
- To compare and contrast COVID-19-induced respiratory distress with bacterial sepsis-induced lung injury.
- To suggest future research directions for identifying endothelium-based biomarkers and treatments for COVID-19.
Main Methods:
- This perspective synthesizes existing research on COVID-19 and related conditions.
- It draws parallels and divergences between COVID-19 and bacterial sepsis regarding lung injury mechanisms.
- It focuses on the endothelial contribution to disease pathophysiology.
Main Results:
- The pulmonary endothelium is proposed as a key player in COVID-19 pathogenesis.
- Similarities and differences between COVID-19 and sepsis-induced lung injury are highlighted.
- The study identifies potential avenues for future research.
Conclusions:
- The endothelium, especially pulmonary endothelium, is central to COVID-19 pathogenesis.
- Understanding endothelial dysfunction in COVID-19 is crucial for developing effective treatments.
- Further investigation into endothelium-based biomarkers and therapies is warranted.
Abstract:
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has affected millions of people globally. Clinically, it presents with mild flu-like symptoms in most cases but can cause respiratory failure in high risk population. With the aim of unearthing newer treatments, scientists all over the globe are striving hard to comprehend the underlying mechanisms of COVID-19. Several studies till date have indicated a dysregulated host immune response as the major cause of COVID-19 induced mortality. In this Perspective, we propose a key role of endothelium, particularly pulmonary endothelium in the pathogenesis of COVID-19. We draw parallels and divergences between COVID-19-induced respiratory distress and bacterial sepsis-induced lung injury and recommend the road ahead with respect to identification of endothelium-based biomarkers and plausible treatments for COVID-19.
Related Concept Videos
Overview of the Vascular System
Regulation of Angiogenesis and Blood Supply
Coronary Artery Disease II: Pathophysiology
Endocarditis I: Introduction

